Sherlot J. Song

Data, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment.

Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment.

Journal: Clinical and molecular hepatology

Published: February 27, 2026

The lean phenotype in metabolic dysfunction-associated steatotic liver disease: diagnostic challenges and prognostic implications: Correspondence to editorial on "Normal-weight metabolic dysfunction-associated steatotic liver disease: reclassification, characteristics, and adverse liver outcomes across diverse populations".

The lean phenotype in metabolic dysfunction-associated steatotic liver disease: diagnostic challenges and prognostic implications: Correspondence to editorial on "Normal-weight metabolic dysfunction-associated steatotic liver disease: reclassification, characteristics, and adverse liver outcomes across diverse populations".

Journal: Clinical and molecular hepatology

Published: January 28, 2026

Challenges in defining MASLD in lean individuals: the impact of the Fatty Liver Index on phenotypic characterisation.

Challenges in defining MASLD in lean individuals: the impact of the Fatty Liver Index on phenotypic characterisation.

Journal: Gut

Published: January 20, 2026

Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.

Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.

Journal: The American journal of gastroenterology

Published: January 19, 2026

Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0.

Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0.

Journal: The American journal of gastroenterology

Published: January 19, 2026

Secular Trend in Glycaemic Management in Type 2 Diabetes Patients With and Without Cirrhosis Between 2000 and 2023: A Territory-Wide Cohort Study.

Secular Trend in Glycaemic Management in Type 2 Diabetes Patients With and Without Cirrhosis Between 2000 and 2023: A Territory-Wide Cohort Study.

Journal: Alimentary pharmacology & therapeutics

Published: January 12, 2026

A cost-effectiveness evaluation framework for treatment for metabolic dysfunction-associated steatohepatitis: Potential and concerns: Editorial on "Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease".

A cost-effectiveness evaluation framework for treatment for metabolic dysfunction-associated steatohepatitis: Potential and concerns: Editorial on "Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease".

Journal: Clinical and molecular hepatology

Published: December 28, 2025

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Validated Nationwide Scoring System for Hepatocellular Carcinoma Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Validated Nationwide Scoring System for Hepatocellular Carcinoma Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 16, 2025

Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study.

Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study.

Journal: Hepatology (Baltimore, Md.)

Published: August 21, 2025

Showing 1-12 of 30

Last Updated: 09/26/2026